The trademark application NUEPOGEN LV was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 22, 2001, and still open for oppositions.
The application was filed in Dutch (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on March 17, 2011.